Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope
Launched by STANFORD UNIVERSITY · Jun 17, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of endoscopes used during a specific procedure called Endoscopic Retrograde Cholangiopancreatography (ERCP), which helps diagnose and treat problems in the bile and pancreatic ducts. The trial aims to see how well each type of endoscope works and whether one causes fewer complications than the other. One type is a duodenoscope with a single-use cover, while the other is a traditional reusable duodenoscope.
To participate in this study, you need to be over 18 years old and undergoing ERCP for issues related to your bile or pancreas. Unfortunately, some individuals, like pregnant women or those with certain infections, cannot join. If you decide to participate, you will help researchers understand which endoscope may be safer and more effective for patients like you. The trial is currently recruiting participants, and everyone is welcome, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing ERCP for biliary and pancreatic conditions
- • Age \> 18 years old
- Exclusion Criteria:
- • Vulnerable patient groups including pregnant women
- • Patients who are unable to consent
- • Patients with known cholangitis
- • Patients with known Carbapenem-Resistant Enterobacteriaceae (CRE) or any other multi-drug resistant organisms (MDRO) infection
- • Surgically altered anatomy except for Billroth I
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Subhas Banerjee, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials